Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,804
Total Claims
$992K
Drug Cost
627
Beneficiaries
$1,581
Cost/Patient
Risk Score Breakdown 21/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-58%
Opioid rate vs peers
0.9% vs 2.2% avg
+12%
Cost per patient vs peers
$1,581 vs $1,411 avg
+20%
Brand preference vs peers
12.8% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
0.9%
Opioid Rate
93
Opioid Claims
$6,334
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,251 claims · $766K
Generic: 8,522 claims · $223K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 206 | $111K |
| Interferon Beta-1b | 11 | $107K |
| Semaglutide | 63 | $99K |
| Rivaroxaban | 65 | $58K |
| Tiotropium Bromide | 38 | $29K |
| Denosumab | 16 | $27K |
| Insulin Glargine,hum.Rec.Anlog | 47 | $24K |
| Cariprazine Hcl | 39 | $24K |
| Empagliflozin | 18 | $23K |
| Insulin Degludec | 20 | $20K |
| Dapagliflozin Propanediol | 53 | $15K |
| Aripiprazole | 53 | $14K |
| Budesonide/Formoterol Fumarate | 22 | $11K |
| Insulin Degludec | 22 | $11K |
| Sucralfate | 51 | $8,603 |
Prescribing Profile
Patient Profile
77
Avg Age
71%
Female
1.66
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About